rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    IMTX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Jefferies reiterates Immatics stock Buy rating after conference
      Nov 17Investing.comIMTX
      Immatics (IMTX) Reports Q3 Loss, Lags Revenue Estimates
      Nov 10Yahoo FinanceIMTX
      Immatics: Q3 Earnings Snapshot
      Nov 10Yahoo FinanceIMTX
      Immatics (IMTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
      Nov 9Yahoo FinanceIMTX
      Immatics (IMTX) PRAME Data Puts A Pricey Valuation Back In Focus

      What the new PRAME data means for Immatics stock Fresh clinical results for Immatics (NasdaqCM:IMTX) are in focus after updated Phase 1b IMA402 and Phase 1 IMA203CD8 data in PRAME expressing solid tumors were shared at the 2026 ESMO meeting. The readout centers on heavily pretreated melanoma and ovarian cancer patients, where Immatics reported objective responses, disease control and durability signals, alongside what management described as manageable safety profiles for both...

      Nov 1Yahoo FinanceIMTX
      Immatics (IMTX) Stock Looks Stretched As PRAME Trial Data Impresses
      Oct 29Yahoo FinanceIMTX
      Should Updated Trial Results Require Action From Immatics (IMTX) Investors?
      Oct 25Yahoo FinanceIMTX
      Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
      Oct 24Yahoo FinanceIMTX
      Bank of America Securities Remains a Buy on Immatics (IMTX)

      Detailed price information for Immatics NV (IMTX-Q) from The Globe and Mail including charting and trades.

      Oct 20The Globe and MailIMTX
      Stifel Initiates Immatics at Buy With $15 Price Target
      Oct 14Yahoo FinanceIMTX
      Stifel initiates Immatics stock with buy rating on melanoma potential
      Oct 13Investing.comIMTX
      Why is Immatics stock climbing today?
      Aug 25Investing.comIMTX
      Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma
      Aug 25Seeking AlphaIMTX
      Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday
      Aug 25BenzingaIMTXMRNAMRVLNYAXPACB
      Immatics Announces $150 Million Underwritten Offering

      Immatics (IMTX) said Tuesday that it has agreed to sell 12,945,916 ordinary shares at $8.69 each, an

      Aug 25Yahoo FinanceIMTX

      This is the newest page. Registered accounts read further back.